Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

PHASE3CompletedINTERVENTIONAL
Enrollment

595

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

March 6, 2020

Study Completion Date

July 24, 2020

Conditions
Psoriasis
Interventions
DRUG

Apremilast

Apremilast, oral, twice daily

OTHER

Placebo

Placebo, oral, twice daily

Trial Locations (64)

10003

Icahn School of Medicine at Mount Sinai, New York

10467

Albert Einstein College of Medicine - Montefiore Medical Center, The Bronx

15213

University of Pittsburgh Medical Center, Pittsburgh

19140

Temple University - Lewis Katz School of Medicine, Philadelphia

20850

Derm Associates, Rockville

Lawrence Green, MD, LLC, Rockville

23502

Virginia Clinical Research Inc, Norfolk

26505

Dermatology Center for Skin Health, Morgantown

27104

Wake Forest University Health Sciences, Winston-Salem

29407

Clinical Research Center of the Carolinas, Charleston

30022

Atlanta Dermatology, Vein and Research Center, PC, Alpharetta

30078

Gwinnett Clinical Research Center, Inc., Snellville

30263

MedaPhase INC, Newnan

30328

Medical Dermatology Specialists, Inc. - Advanced Medical Research, Atlanta

33134

Florida Academic Centers Research and Education, Coral Gables

33144

International Dermatology Research, Miami

33180

Center for Clinical and Cosmetic Research, Miami

33437

Total Vein and Skin, LLC, Boynton Beach

33612

University of South Florida - Carol and Frank Morsani Center for Advanced Health Care, Tampa

34470

Renstar Medical Research, Ocala

35205

Total Skin & Beauty Dermatology Center, Birmingham

43210

Ohio State University Wexner Medical Center, Columbus

45324

Wright State Physicians, Fairborn

46256

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

48202

Henry Ford Medical Center - New Center One, Detroit

55432

Minnesota Clinical Study Center, Fridley

63117

Central Dermatology, St Louis

70006

Clinical Trials Management LLC, Metairie

72758

Northwest Arkansas Clinical Trials Center, PLLC / Hull Dermatology, Rogers

72916

Johnson Dermatology Clinic, Fort Smith

77598

Center for Clinical Studies, Webster

78660

Austin Institute for Clinical Research, Pflugerville

80045

University of Colorado Hospital - Dermatology Clinic, Aurora

84107

University of Utah MidValley Dermatology, Murray

89148

JDR Dermatology Research, LLC, Las Vegas

90045

Dermatology Research Associates, Los Angeles

90404

Clinical Science Institute, Santa Monica

92123

TCR Medical Corporation, San Diego

94118

University of California San Francisco Psoriasis and Skin Treatment Center, San Francisco

01915

ActivMed Practices & Research Inc, Beverly

02114-2517

Massachusetts General Hospital, Boston

08520

Psoriasis Treatment Center of Central New Jersey, East Windsor

02919

Clinical Partners, LLC, Johnston

T3A 2N1

Institute for Skin Advancement, Calgary

T5K 1X3

Stratica Medical, Edmonton

V3R 6A7

Chih-Ho Hong Medical, Inc., Surrey

V3V 0C6

Enverus Medical Research, Surrey

R3CON2

Winnipeg Clinic Dermatology Research, Winnipeg

R3M 3Z4

SkinWise Dermatology, Winnipeg

E3B 1G9

Brunswick Dermatology Centre, Fredericton

A1A 4Y3

Karma Clinical Trials, St. John's

L4M 7G1

SimcoDerm Medical and Surgical Dermatology Center, Barrie

N1L 0B7

Guelph Dermatology Research, Guelph

N6H 5L5

DermEffects, London

L3P 1X2

Lynderm Research, Markham

P1B 3Z7

North Bay Dermatology Centre, North Bay

K9J 5K2

Skin Center for Dermatology, Peterborough

M3H 5Y8

Toronto Research Centre, Toronto

M4W 2N2

Sameh Hanna Medicine Professional Corporation DBA Dermatology on Bloor, Toronto

N2J 1C4

K. Papp Clinical Research, Waterloo

N8W 5L7

Windsor Clinical Research Inc., Windsor

J2B 5L4

Dr Isabelle Delorme inc, Drummondville

J7Z 7E2

Dre Angelique Gagne-Henley M.D. Inc., Saint-Jérôme

S7K 0H6

Skinsense Medical Research, Saskatoon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY